Grace Therapeutics - 53 Year Dividend History | GRCE
Historical dividend payout and yield for Grace Therapeutics (GRCE) since 1971. The current TTM dividend payout for Grace Therapeutics (GRCE) as of December 20, 2024 is $0.00. The current dividend yield for Grace Therapeutics as of December 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.041B |
$0.000B |
|
Grace Therapeutics Inc. is a late-stage biopharma company advancing GTx-104, its novel injectable formulation of nimodipine which addresses high unmet medical needs for a rare disease, aneurysmal subarachnoid hemorrhage. Grace Therapeutics Inc., formerly known as Acasti Pharma Inc., is based in Princeton, New Jersey.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
